Form 4: USPH Executive Granted 10,000 Restricted Shares

Sentiment:

Insider Transaction Report


U.S. Physical Therapy's EVP, General Counsel & Secretary, Richard Binstein, was granted 10,000 restricted common shares.

Summary

  • Richard Binstein, Executive Vice President, General Counsel, and Secretary of U.S. Physical Therapy Inc. (USPH), was granted 10,000 shares of common stock.
  • The shares were granted as restricted stock under the Company's Amended and Restated 2003 Stock Incentive Plan.
  • The restrictions on these 10,000 shares will lapse in 15 quarterly installments of 624 shares, beginning on May 20, 2026.
  • Subsequent vesting dates for the 624-share installments include March 6, May 20, August 20, and November 20 of each year from 2026 through 2029.
  • A final installment of 640 shares from this grant will vest on March 6, 2030, contingent on continued employment.
  • Following this transaction, Richard Binstein beneficially owns a total of 27,867 shares.
  • The total restricted shares beneficially owned, including this new grant, amount to 22,624 shares, with various vesting schedules extending through March 6, 2030.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, primarily for executive retention and alignment of interests, which is a standard and healthy corporate governance practice. It does not indicate a significant shift in company fundamentals.

Positives

  • The grant of restricted stock aligns the executive's interests with those of shareholders, promoting long-term commitment and performance.
  • This compensation structure serves as a retention mechanism for key management personnel, ensuring continuity in leadership.
  • The vesting schedule, extending to 2030, indicates a long-term incentive for the executive.

Risks

  • The vesting of restricted shares is contingent upon the executive's continued employment with the Company as of the specified vesting dates.

Future Outlook

The future outlook for Richard Binstein's equity compensation involves a structured vesting schedule for his restricted stock, extending through March 6, 2030, contingent on his continued employment with the company.

Industry Context

StockSavvy.ai notes that the grant of restricted stock to an executive is a common practice in the U.S. physical therapy industry and broader corporate landscape. It serves as a standard component of executive compensation packages, designed to incentivize long-term performance and retain key talent by aligning their financial interests with the company's success.

Comparison to Industry Standards

  • Executive compensation packages, including restricted stock grants, are standard across publicly traded companies, such as Select Medical Holdings Corporation (SEM) and Encompass Health Corporation (EHC), which also utilize equity incentives to attract and retain top management.
  • The multi-year vesting schedule is typical for such grants, comparable to practices seen in healthcare services companies, ensuring executives remain committed over an extended period rather than short-term gains.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Executive CompensationGrant of 10,000 restricted shares to EVP, General Counsel & Secretary Richard Binstein under the Company's Amended and Restated 2003 Stock Incentive Plan.02/23/2026Reinforces executive retention and aligns management's long-term interests with shareholder value through equity ownership.

Related Party Transactions

  • Grant of 10,000 restricted shares of common stock to Richard Binstein, an executive officer of the company, as part of his compensation package.

Stakeholder Impact

  • Shareholders: Potential for minor future dilution as shares vest, but also benefit from increased executive alignment and retention.
  • Employees: Reinforces the company's commitment to executive compensation and retention, potentially signaling stability.
  • Executive (Richard Binstein): Receives significant equity compensation, increasing personal wealth and long-term incentive to perform.

Next Steps

  • Vesting of 624 restricted shares on May 20, 2026, and subsequently on various quarterly dates through November 20, 2029.
  • Vesting of 640 restricted shares on March 6, 2030, contingent on continued employment.

Key Dates

DateDescription
02/23/2026Date of earliest transaction (grant of 10,000 restricted shares)
03/06/2026Vesting of 1,554 restricted shares (from total 22,624)
05/20/2026First vesting of 624 shares from the 10,000 grant; also vesting of 1,870 restricted shares (from total 22,624)
08/20/2026Vesting of 624 shares from the 10,000 grant; also vesting of 1,870 restricted shares (from total 22,624)
11/20/2026Vesting of 624 shares from the 10,000 grant; also vesting of 1,870 restricted shares (from total 22,624)
03/06/2027Vesting of 624 shares from the 10,000 grant; also vesting of 1,876 restricted shares (from total 22,624)
05/20/2027Vesting of 624 shares from the 10,000 grant; also vesting of 1,636 restricted shares (from total 22,624)
08/20/2027Vesting of 624 shares from the 10,000 grant; also vesting of 1,636 restricted shares (from total 22,624)
11/20/2027Vesting of 624 shares from the 10,000 grant; also vesting of 1,636 restricted shares (from total 22,624)
03/06/2028Vesting of 624 shares from the 10,000 grant; also vesting of 1,640 restricted shares (from total 22,624)
05/20/2028Vesting of 624 shares from the 10,000 grant; also vesting of 1,130 restricted shares (from total 22,624)
08/20/2028Vesting of 624 shares from the 10,000 grant; also vesting of 1,130 restricted shares (from total 22,624) and 624 shares (from total 22,624)
11/20/2028Vesting of 624 shares from the 10,000 grant; also vesting of 1,130 restricted shares (from total 22,624)
03/06/2029Vesting of 624 shares from the 10,000 grant; also vesting of 1,134 restricted shares (from total 22,624)
05/20/2029Vesting of 624 shares from the 10,000 grant; also vesting of 624 restricted shares (from total 22,624)
11/20/2029Vesting of 624 shares from the 10,000 grant; also vesting of 624 restricted shares (from total 22,624)
03/06/2030Final vesting of 640 shares from the 10,000 grant; also final vesting of 640 restricted shares (from total 22,624)

Recommendation

hold

This Form 4 reports a routine restricted stock grant to an executive, which is a standard component of compensation and retention strategy. It does not provide new information that would fundamentally alter the investment thesis for U.S. Physical Therapy Inc., thus a 'hold' recommendation is appropriate as it maintains the status quo.

Keywords

USPH, U.S. Physical Therapy, Richard Binstein, Form 4, restricted stock, executive compensation, stock grant, vesting schedule, insider transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.